Diclofenac sodium-loaded eudragit® microspheres: Optimization using statistical experimental design

Journal of Pharmaceutical Innovation

Volumn 8, Issue 4, 2013, Pages 276-287

  Deshmukh, Rameshwar K ^a   Naik, Jitendra B ^a  

^a NORTH MAHARASHTRA UNIVERSITY   (India)

Author keywords

Biocompatible polymers; Design and optimization; Diclofenac sodium; Encapsulation; Response surfacemethodology

Indexed keywords

DICLOFENAC; EUDRAGIT; MICROSPHERE; POLYMER; POLYVINYL ALCOHOL; SURFACTANT;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; ENCAPSULATION; EVAPORATION; EXPERIMENTAL DESIGN; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATHEMATICAL ANALYSIS; PH; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; X RAY POWDER DIFFRACTION;

EID: 84902687355     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-013-9167-9     Document Type: Article

References (54)

1. Arias JL, Lopez-Viota M, Lopez-Viota J, Delgado AV. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. Int J Pharm. 2009;382(1-2):270-6. doi: 10.1016/j.ijpharm.2009.08.019.
2. Edelson JT, Tosteson AN, Sax P. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. JAMA. 1990;264(1):41-7. (Pubitemid 20209168)
3. Barrier CH, Hirschowitz BI. Controversies in the detection and management of nonsteroidal anti-inflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum. 1989;32:926-32. (Pubitemid 19181017)
4. Pincus T, Griffin M. Gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs: new insights from observational studies and functional status questionnaires. Am J Med. 1991;91(3):209-12.
5. Sostres C, Gargallo CJ, Arroyo MT, Ganas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24:121-32.
6. Thiefin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine. 2005;72(4):286-94. doi:10.1016/j.jbspin.2004.10.004. (Pubitemid 40994974)
7. Pilotto A, Sancarlo D, Addante F, Scarcelli C, Franceschi M. Nonsteroidal anti-inflammatory drug use in the elderly. Surg Oncol. 2010;19(3):167-72. doi:10.1016/j.suronc.2009.11.014.
8. Lamprecht A, Torres HR, Schafer U, Lehr CM. Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease. J Control Release. 2000;69(3):445-54. doi:10.1016/S0168-3659(00)00331-X.
9. Herrmann J, Bodmeier T. Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions. Int J Pharm. 1995;126:129-38. (Pubitemid 26015630)
10. Yoo HS. Preparation of biodegradable polymeric hollow microspheres using O/O/W emulsion stabilized by Labrafil®. Colloids Surf B. 2006;52:47-51. (Pubitemid 44301875)
11. Polard E, Corre PS, Chevanne F, Verge RL. In vitro and in vivo evaluation of polylactide and polylactide-co-glycolide microspheres of morphine for site-specific delivery. Int J Pharm. 1996;134:37-46. (Pubitemid 26001125)
12. Bodmeier R, Chen H, Tyle P, Jarosz P. Pseudoephedrine HCL microspheres formulated into an oral suspension dosage form. J Control Release. 1991;15:65-77.
13. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 2008;363(1-2):26-39. doi:10.1016/j.ijpharm.2008.07.018.
14. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release. 2005;102(2):313-32. doi:10.1016/j.jconrel.2004.10.015. (Pubitemid 40093756)
15. Kilicarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm. 2003;252(1-2):99-109. (Pubitemid 36126618)
16. Eudragit Data Sheets. Industrial Product Division, Röhm Pharma GmbH, Weiterstadt, Germany; 2002.
17. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. Washington, DC: Pharmaceutical Press and American Pharmacists Association; 2009.
18. Barzegar-Jalali M, Alaei-Beirami M, Javadzadeh Y, Mohammadi G, Hamidi A, Andalib S, et al. Comparison of physicochemical characteristics and drug release of diclofenac sodium-Eudragit RS100 nanoparticles and solid dispersion. Powder Technol. 2012;219:211-6.
19. Bas D, Boyaci IH. Modeling and optimization I: usability of response surface methodology. J Food Eng. 2007;78(3):836-45. doi:10.1016/j.jfoodeng.2005. 11.024.
20. Chopra S, Patil GV, Motwani SK. Release modulating hydrophilic matrix systems of lasartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm. 2007;66:73-82. (Pubitemid 46412965)
21. Kehoe S, Kilcup N, Boyd D. Evaluation of cytotoxicity for novel composite embolic microspheres: material optimization by response surface methodology. Mater Lett. 2012;86:13-7. doi:10.1016/j.matlet.2012.06.087.
22. Kettaneh-Wold N. Use of experimental design in the pharmaceutical industry. J Pharm Biomed Anal. 1991;9(8):605-10.
23. Ragonese R, Macka M, Hughes J, Petocz P. The use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. J Pharm Biomed Anal. 2002;27:995-1007. (Pubitemid 34142572)
24. Martins SA, Prazeres DM, Fonseca LP, Monteiro GA. Application of central composite design for DNA hybridization onto magnetic microparticles. Anal Biochem. 2009;391(1):17-23. doi:10.1016/j.ab.2009.05.006.
25. Jose S, Fangueiro JF, Smitha J, Cinu TA, Chacko AJ, Premaletha K, et al. Cross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testing. Colloids Surf B. 2012;92:175-9. doi:10.1016/j.colsurfb. 2011.11.040.
26. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev. 1997;25:25-42. (Pubitemid 27497672)
27. Pund S, Joshi A, Vasu K, Nivsarkar MCS. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site specific release isoniazid pelletes. Int J Pharm. 2010;388:64-72.
28. Al haushey L, Bolzinger MA, Bordes C, Gauvrit JY, Briancon S. Improvement of a bovine serum albumin microencapsulation process by screening desing. Int J Pharm. 2007;344:16-25.
29. Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm. 2010;76(2):189-99. doi:10.1016/j.ejpb.2010.07.007.
30. Krishnaiah D, Bono A, Sarbatly R, Nithyanandam R, Anisuzzaman SM. Optimisation of spray drying operating conditions of Morinda citrifolia L. fruit extract using response surface methodology. J King Saud Univ Eng Sci. 2012. doi:10.1016/j.jksues.2012.10.004.
31. Bolton S, Bon C. Pharmaceutical statitics practical and clinical application. 5th ed. New York: Informa Healthcare; 2009.
32. Fini A, Fazio G, Feroci G. Solubility and solubilization properties of non-steroidal anti-inflammatory drugs. Int J Pharm. 1995;126:95-102. (Pubitemid 26015628)
33. Gohel MC, Jani GK. Effects of selected formulation parameters on the entrapment of diclofenac sodium in ethyl cellulose microspheres. J Control Release. 1997;43:245-50. (Pubitemid 26390972)
34. Indian Pharmacopoeia Commission Ghaziabad. Indian Pharmacopoeia. 2010;562-587.
35. Korsemeyer R, Gurny RNP. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
36. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci. 1969;58(10):1253-7.
37. Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determination: theoretical consideration and application to nondisintegrating dosage forms. J Pharm Sci. 1967;56(10):1238-42.
38. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50(10):874-5.
39. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145-9.
40. Cobby J, Mayersohn M, Walker GC. Influence of shape factors on kinetics of drug release frommatrix tablets. II. Experimental. J Pharm Sci. 1974;63(5):732-7.
41. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23:923-31.
42. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110-1.
43. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix swelling and dissolution. Pharm Res. 1988;5(8):488-94.
44. Bamba M, Puisieux F, Marty J, Carstensen J.Mathematicalmodel for release of drug from gel-forming sustained release preparations. Int J Pharm. 1979;3:87-92.
45. Meyer RH, Montgomery DC. Response surface methodology: process and product optimization using designed experiments. New York: Wiley; 2002.
46. Montgomery DC. Introduction to statistical quality control. 4th ed. New York: Wiley; 2008.
47. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed-Nanotechnol. 2012;8(2):237-49. doi:10.1016/j.nano.2011.06.004.
48. Nayak AK, Pal D, Pradhan J, Hasnain MS. Fenugreek seed mucilage-alginate mucoadhesive beads of metformin HCl: design, optimization and evaluation. Int J Biol Macromol. 2013;54:144-54.
49. Shivakumar HN, Desai BG, Deshmukh G. Design and optimization of diclofenac sodium controlled release solid dispersion by response surface methodology. Indian J Pharm Sci. 2008;70:22-30. (Pubitemid 351670564)
50. Pignatello R, Ferro M, Guidi GD, Salemi G, Vandelli MA, Guccione S, et al. Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100® and RL100®. Int J Pharm. 2001;218:27-42. (Pubitemid 32406154)
51. Paloma ME, Ballesteros MP, Frutos P. Analysis of diclofenac sodium and derivatives. J Pharm Biomed Anal. 1999;21:83-94. (Pubitemid 29430145)
52. Naik JB, Deshmukh RK, Kamble VV. Development of sustained released microparticles of diclofenac sodium using polymer complex by spray drier. Am J PharmTech Res. 2013;3.
53. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydropropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-57. (Pubitemid 32434400)
54. Mourao SC, da Silva C, Bresolin TM, Serra CH, Porta V. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet. Int J Pharm. 2010;386(1-2):201-7. doi:10.1016/j.ijpharm.2009.11.022.